pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›approval
approval
save

GLYCOPYRROLATE — FDA approval

October 27, 2025updated 4mo ago
community read0 votes

Sponsor: AJENAT PHARMS. Form: SOLUTION. Route: ORAL

view source ↗
Data sources
fda approvals
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • approvalCONEXXENCE: CONEXXENCE (DENOSUMAB-BNHT) — FDA approvalOct 29, 2025
  • approvalDALBAVANCIN HYDROCHLORIDE — FDA approvalOct 23, 2025
  • approvalSTIMUFEND: STIMUFEND (PEGFILGRASTIM-FPGK) — FDA approvalOct 21, 2025
  • device recallFresenius Kabi USA, LLC device recall (Cls II)Nov 3, 2025
  • device recallFresenius Kabi USA, LLC device recall (Cls I)Nov 3, 2025
  • approvalDALBAVANCIN HYDROCHLORIDE: DALBAVANCIN HYDROCHLORIDE — FDA approvalNov 10, 2025

🐶 often sniffed alongside

top 8
  • tagApproval258 co-mentions · 129 sources
  • drugRNS-60236 co-mentions · 149 sources
  • drugDIPRIVAN78 co-mentions · 39 sources
  • drugPROPOFOL39 co-mentions · 39 sources
  • drugDILAUDID-HP38 co-mentions · 19 sources
  • tagRecall33 co-mentions · 20 sources
  • drughydromorphone hydrochloride ER19 co-mentions · 19 sources
  • drugHYDROMORPHONE HYDROCHLORIDE19 co-mentions · 19 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?